Echocardiographic impact of hydration status in dialysis patients;Repercusión ecocardiográfica del estado de hidratación en los pacientes en diálisis

Nefrologia

Volumn 32, Issue 1, 2012, Pages 94-102

  Juan García, Isabel ^a   Puchades, María J ^a   Sanjuán, Rafael ^a   Torregrosa, Isidro ^a   Solís, Miguel A ^a   González, Miguel ^a   Blasco, Marisa ^a   Martínez, Antonio ^a   Miguel, Alfonso ^a  

^a HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

Author keywords

Bioimpedance spectroscopy; Left arterial volumen index; Left ventricular hypertrophy; Volume status

Indexed keywords

ARTICLE; CROSS-SECTIONAL STUDY; ECHOGRAPHY; FEMALE; HEART LEFT VENTRICLE HYPERTROPHY; HUMAN; MALE; METABOLIC DISORDER; MIDDLE AGED; PERITONEAL DIALYSIS; RENAL REPLACEMENT THERAPY;

CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; HYPERTROPHY, LEFT VENTRICULAR; MALE; MIDDLE AGED; PERITONEAL DIALYSIS; RENAL DIALYSIS; WATER-ELECTROLYTE IMBALANCE;

EID: 84858317590     PISSN: 02116995     EISSN: None     Source Type: Journal    
DOI: 10.3265/Nefrologia.pre2011.Nov.10867     Document Type: Article

References (42)

1. Locatelli F, Marcelli D, Conte F, D'Amico M, Del Vecchio L, Limido A, et al. Cardiovascular disease in chronic renal failure: the challenge continues. Nephrol Dial Transplant 2000;15 (Suppl.5):69-80.
2. Tonelli M, Wiebe N, Culleton B, House A, Rabbat C, Fok M, et al. Chronic kidney disease and mortality risk: a systematic review. J Am Soc Nephrol 2006;17:2034-47.
3. Sarnak MJ, Levey AS, Schoolwerth AC, Coresh J, Culleton B, Hamm LL, et al.; American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Circulation 2003;108(17):2154-69.
4. Parfrey PS, Foley RN. The clinical epidemiology of cardiac disease in chronic renal failure. J Am Soc Nephrol 1999;10:1606-15.
5. Silverberg DS, Wexler D, Iaina A, SteinbruchS, Wollman Y, Schwartz D. Anemia, chronic renal disease and congestive heart failure-the cardio renal anemia syndrome: the nedd for cooperation between cardilogists and nefephrologists. Int Urol Nephrol 2006;38:295-310.
6. Kuhlmann MK, Zhu F, Seibert E, Levin NW. Bioimpedance, dry weight and blood pressure control: new metrhods and consequences. Curr Opin Nephrol Hypertens 2005;14:543-9.
7. Bargnoux AS, Kloudche K, Fareh J, Barazer I, Villard-Saussine S, Dupuy AM, et al. Prohormone brain natriuretic peptide (proBNP), BNP and Nterminal-proBNP circulating levels in chronic hemodialysis patients. Correlation with ventricular function, fluid removal and effect of hemodiafiltration. Clin Chem Lab Med 2008;46:1019-24.
8. Matthie J, Zarowitz B, De Lorenzo A, Andreoli A, Katzarski K, Pan G, et al. Analytic assessment of the various bioimpedance methods used to estimate body water. J Appl Physiol 1998;84:1801-16.
9. Moissl UM, Wabel P, Chamney PW, Bosaeus I, Levin NW, Bosy-Westphal A, et al. Body fluid volume determination via body composition spec troscopy in health and disease. Physiol Meas 2006;27:921-33.
10. Moissl U, Bosaeus I, Lemmey A, Hovgesen S, Wabel P, Chamney PW, et al. Validation of a 3C model for determination of body fat mass. J Am Soc Nephrol 2007;18:257A.
11. Passauer J, Petrov H, Schleser A, Leicht J, Pucalka K. Evaluation of clinical dry weight assessment in haemodialysis patients using bioimpedance specctroscopy: a cross-sectional study. Nephrol Dial Transplant 2010;25:545-51.
12. Wizemann V, Rode C, Wabel P. Whole-body spectroscopy (BCM) in the assessment of normovolemia in hemodialysis patients. Contrib Nephrol 2008;161:115-8.
13. Lindley E, Devine Y, Hall L, Cullen M, Cuthbert S, Woodrow G, et al. A Ward-based procedure for assessment of fluid status in peritoneal dialysis patients using bioimpedance spectroscopy. Perit Dial Int 2005;25 Suppl 3:S46-S48.
14. Wizemann V, Wabel P, Chamney P, Zaluska W, Moissl U, Rode Ch, et al. The mortality risk of overhydration in haemodialysis patients. Nephrol Dial Transplant 2009;24(5):1574-9.
15. Devereux RB, Lutas EM, Casale PN, Kligfield P, Eisenberg RR, Hammond IW, et al. Standardization of M-mode echocardiographic left ventricular anatomic measurements. J Am Coll Cardiol 1984;4(6):1222-30.
16. Devereux RB, Alonso DR, Lutas EM, Gottlieb GJ, Camp E, Sachs I, et al. Echocardiographic assessment of Left Ventriular Hypertrophy: Comparison to Necropsy Findigs. Am J Cardiol 1986;57(6):450-8.
17. Quiñoles MA, Otto CM, Stoddard M, Waggoner A, Zoghbi WA. Recommendations for quantification of Doppler echocardiography: a report from the Doppler Quantification Task Force of the nomenclature and Standards Committee of the American Society of Echocardiography. J Am Soc Echocardiogr 2002;15(2):167-84.
18. Tripepi G, Benedetto FA, Mallamaci F, Tripepi R, Malatino L, Zoccali C. Left atrial volumen in end-stage renal disease: a prospective cohort study. J Hypertens 2006;24:1173-80.
19. Tripepi G, Benedetto FA, Mallamaci F, Tripepi R, Malatino L, Zoccali C. Left atrial volumen monitoring and cardiovascular risk in patients with end-stage renal disease: a prospective cohort stuydy. J Am Soc Nephrol 2007;18:1316-22.
20. Wabel P, Moissl U, Chamney P, Jirka T, Machek P, Ponce P, et al. Towards improvend cardiovascular manegement: the necessity of combining blood pressure and fluid overload. Nephrol Dial Transplant 2008;9:2965-71.
21. Leunissen KM, Kouw P, Kooman JP. New techniques to determine fluid status in hemodialyzed patients. Kidney In 1993;41:S50-S56.
22. Bargnoux AS, Klouche K, Fareh J, Barazer I, Villard-Saussine S, Dupuy AM, et al. Prohormone brain natriuretic peptide (proBNP), BNP and Nterminal-proBNP circulating levels inchronic hemodialysis patients. Correlation with ventricular function, fluid removal and effect of hemodiafiltration. Clin Chem Lab Med 2008;46:1019-24.
23. Devolder I, Verleysen A, Vijt D, Vanholder R, Van Biesen W. Body composition, hydration, and related parameters in hemodialysis versus peritoneal dialysis patients. Perit Dial Int 2010;30(2):208-14.
24. Lopot F, Nejedly B, Novotna H, Mackova M, Sulkova S. Age-related extracellular to total body water volume ratio (ECV/TBW)- Can it be used for «dry weight» determination in dialysis patients? Application of ultifrequency bioimpedance measurement. Int J Artif Organs 2002;25:762-9.
25. Plum J, Schoenicke G, Kleophas W, Kulas W, Steffens F, Azem A, et al. Comparison of body fluid distribution between chronic haemodialysis and peritoneal dialysis patients as assessed by biophysical and biochemical methods. Nephrol Dial Transplant 2001;16:2378-85.
26. Kooman JP, Gladziwa U, Böcker G, Wijnen AG, van Bortel K, Luik AJ, et al. Blood pressure during the interdialytic period in hemodialysis patients; estimación of representative pressure values. Nephrol Dial Transplant 1992;7:917-23.
27. Menon MK, Naimark DM, Bargman J, Vas SI, Oreopoulos DG. Long-term blood pressure control in a cohort of PD patients and its association with residual renal function. Nephrol Dial Transplant 2001;16:2207-13.
28. Lysaght MJ, Vonesh EF, Gotch F, Ibels L, Keen M, Lindholm B, et al. The influence of dialysis traatment modality on the decline of remaining renal function. ASAIO Trans 1991;37:598-604.
29. Gámez C, Teruel JL, Ortuño J. Evolución de la función renal residual en enfermos tratados con hemodiálisis. Nefrologia 1992;12:125-9.
30. Foley RN, Parfrey PS, Harnett JD, Kent GM, Martin CJ, Murray DC, et al. Clinical and echocardiographic disease in patients starting end-stage renal disease therapy. Kidney Int 1995;47(1):186-92.
31. López Gómez JM, Verde E, Pérez García R. Blood pressure left ventricular hipertrophy and long term prognosis in hemodialysis patients. Kidney Int Suppl 1998;68:S92-8.
32. Levin D, Singer J, Thompson CR. Prevalent lsft hypertrophy in the predialysis populations: identiffying opportunities for intervention. Am J Kidney Dis 1996;27:347-54.
33. Bossola M, Tazza L, Vulpio C, Luciani G. Is regression of left ventricular hypertrophy in maintenance hemodialysis patients possible? Semin Dial 2008;21(5):422-30.
34. Wang AY, Wangg M, Woo J, Law MC, Chow KM, Li PY, et al. A novel association between resudual renal function and left ventricular hypertrophy in peritoneal dialysis patients. Kidney Int 2002;62:639-47.
35. Foley RN, Parfrey PS, Kent GM, Harnett JD, Murray DC, Barre PE. Longterm evolution of cardiomiopathy in dialysis patients. Kidney Int 1998;54:1720-5.
36. Foley RN, Parfrey PS, Morgan J, Barré PE, Campbell P, Cartier P, et al. Effect of hemoglobin levels in hemodialysis patients with asymptomatic cardiomyopathy. Kidney Int 2000;58(3):1325-35.
37. Ardeleanu S, Panaghiu L, Prisada O, Sasca u R, Voroneanu L, Hogas, S, et al. up study. Int Urol Nephrol. [Epub ahead of print]
38. London GM, Pannier B, Guerin AP, Blacher J, Marchais SJ, Darne B, et al. Alterations of left ventricular hypertrophy in and survival of patients receiving hemodialysis: follow-up of an interventional study. J Am Soc Nephrol 2001;12(12):2759-67.
39. Levin A, Thompson CR, Ethier J, Carlisle EJ, Tobe S, Mendelssohn D, et al. Left ventricular mass index increase in early renal disease: impact of decline in hemoglobin. Am J Kidney Dis 1999;34(1):125-34.
40. Wang AY, Wang M, Lam CW, Chan IH, Lui SF, Sanderson JE. Heart Failure in Long-Term Peritoneal Dialysis Patients: A 4-Year Prospective Analysis. Clin J Am Soc Nephrol 2011;6(4):805-12.
41. Io H, Ro Y, Sekiguchi Y, Shimaoka T, Inuma J, Hotta Y, et al. Cardiac function and structure in longitudinal analysis of echocardiography in peritoneal dialysis patients. Perit Dial Int 2010;30(3):353-61.
42. Tsang TS, Barnes ME, Gersh BJ, Bailey KR, Seward JB. Left atrial volume as a morphophysiologic expression of left ventricular diastolic dysfunction and relation to cardiovascular risk burden. Am J Cardiol 2002;90:1284-9.